Connect with us

Health

Province looks at vaccine priority for Surrey educators – Burns Lake Lakes District News

Published

 on


Surrey teachers may receive their COVID-19 vaccine sooner rather than later.

Provincial health officer Dr. Bonnie Henry talked about the virus risk in the City of Surrey at a media availability Monday afternoon. She said the number of cases in Surrey has prompted health officials to consider giving vaccine priority to Surrey educators over other teachers in the province.

Surrey is, “by far,” the highest risk area in the province, Henry said.

“We don’t have enough vaccine to do everyone in the school system right now, so we will be prioritizing where the risk is greatest,” Henry said.

Last week, officials announced frontline workers, including police, firefighters, child-care, grocery store, postal and K-12 education staff would be getting the vaccine in April.

Henry said teachers are among the focus of immunization due to the disruption caused to society when cohorts of students are requested to isolate. She said school COVID-19 safety plans are effective, and that COVID-19 cases related to the school setting is reflective of the community.

“It’s been particularly a concern in the Surrey School District where we see exposures in schools and it’s very disruptive,” she said.

Henry noted that while the province is looking at prioritizing Surrey educators, “all of the educators in the school system are a priority group because of the role they play in the education system.”

Monday, Henry reported 556 new cases in the 24 hours up to Saturday, 698 up to Sunday and 631 as of Monday with 15 deaths related to the virus over the three days.

RELATED: Younger people with COVID now requiring longer hospital, ICU stays: Dr. Henry

Henry noted an increase of the B117 (U.K.) variant of the virus, which is more transmissible. Workplaces and indoor gatherings continue to be the leading venue where the virus is spread.

She also said there’s been a “concerning” increase in the number of younger people ending up in hospital or intensive care due to COVID-19.

“What we’re seeing is that people in our community, younger age groups, requiring hospitalization and needing to be hospitalized for longer periods of time,” Henry said.

So far, about 10.5 per cent of B.C.’s adult population has been vaccinated against the novel coronavirus – a percentage far below what’s needed for herd immunity and that is heavily skewed towards long-term care home residents, seniors and people in isolation communities.

Henry noted that while the risk is still much higher for seniors and other older people, the younger people who are ending up in hospital are requiring more time in the ICU.

“We have seen several young people in their 30s and 40s who’ve unfortunately, tragically, been severely affected by COVID.”

CoronavirusSurrey

Get local stories you won’t find anywhere else right to your inbox.
Sign up here

Let’s block ads! (Why?)



Source link

Continue Reading

Health

COVID cases in Ontario could spike to 30,000 per day by June

Published

 on

TORONTO (Reuters) – New cases of COVID-19 in Canada‘s most populous province could rise more than six fold, topping 30,000 per day by early June if public health measures are weak and vaccination rates remain flat, a panel of experts advising the province of Ontario said on Friday.

Even if measures to control the virus are “moderate,” the number of patients in Ontario ICUs could reach 2,000 in May, up from 695 on Friday.

The College of Physicians and Surgeons of Ontario told doctors last week they may soon have to decide who can and cannot receive intensive care.

 

(Reporting by Allison Martell; Editing by Chris Reese)

Continue Reading

Health

Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track

Published

 on

ZURICH (Reuters) – U.S. drugmaker Moderna expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union– and Swiss-bound shipments are on track, a spokesperson said.

The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland’s Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States.

“The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain,” Moderna said in a statement.

Lonza didn’t immediately return a phone call and email seeking comment on any issues in its production.

 

(Reporting by John Miller; editing by David Evans)

Continue Reading

Health

Moderna says vaccines to Canada to be delayed due to Europe shortfall

Published

 on

(Reuters) -Moderna Inc said on Friday a shortfall in COVID-19 vaccine doses from its European supply chain will lead to a delay in deliveries to some countries including Canada.

The drugmaker would be delivering only 650,000 doses by April end as opposed to 1.2 million, Canada‘s Procurement Minister Anita Anand said in a statement.

She said one to two million doses of the 12.3 million doses scheduled for delivery by Moderna in the second quarter would be delayed until the third.

Moderna officials in Europe did not immediately comment on the reason for the delays or give the total number of countries that would be impacted.

“Vaccine manufacturing is a highly complex process and a number of elements, including human and material resources have factored into this volatility,” said Patricia Gauthier, an executive at Moderna Canada.

Canada has distributed a total of 2.82 million doses of the Moderna vaccine as of April 14 and 12.7 million doses of COVID-19 vaccines in total.

Moderna has been aiming to deliver 700 million to 1 billion doses of the COVID-19 globally this year, including from plants in Europe and the United States.

Swiss contract drug manufacturer Lonza makes active ingredients for Moderna’s vaccine in Visp, but it was still ramping up three new production lines that once operational would be able to produce 300 million shots annually.

The current supply, demand and distribution landscape has led the drugmaker to make adjustments in the expected second-quarter deliveries, Gauthier said.

(Reporting by Manas Mishra in Bengaluru, Allison Martell in Toronto and John Miller in Zurich; Editing by Arun Koyyur)

Continue Reading

Trending